Analystreport

La Jolla Pharmaceutical (NASDAQ: LJPC) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

La Jolla Pharmaceutical Company  (LJPC) 
Last la jolla pharmaceutical company earnings: 3/2 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations